| Followers | 19 |
| Posts | 6606 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Sunday, June 29, 2025 8:52:59 AM
WQLF SAYS ; CC12 TESTIMONY YQU Understand,
Have Mercy WQLF ahoooooo
Posts by CC12 Board Date/Time
I bought mail order from a small shop CV Sciences Inc (CVSI) 06/28/2025 10:11:49 PM
Lunar Fox would sell well at REI. Great CV Sciences Inc (CVSI) 05/20/2025 08:52:53 AM
I made the Lunar Fox Bolognese and Whisked. CV Sciences Inc (CVSI) 03/30/2025 10:21:26 AM
CC12
Re: None
Wednesday, 03/19/2025 9:00:12 PM
I just bought these Lunarfox
Products mail order from Something Better. Ingredients look good and good shelf life.
Wolfman Jack Said; Have Mercy Happy SUCCESSFUL LUNAR LANDING You Understand Ahooooooo
Have Mercy WQLF ahoooooo
Posts by CC12 Board Date/Time
I bought mail order from a small shop CV Sciences Inc (CVSI) 06/28/2025 10:11:49 PM
Lunar Fox would sell well at REI. Great CV Sciences Inc (CVSI) 05/20/2025 08:52:53 AM
I made the Lunar Fox Bolognese and Whisked. CV Sciences Inc (CVSI) 03/30/2025 10:21:26 AM
CC12
Re: None
Wednesday, 03/19/2025 9:00:12 PM
I just bought these Lunarfox
Products mail order from Something Better. Ingredients look good and good shelf life.
Wolfman Jack Said; Have Mercy Happy SUCCESSFUL LUNAR LANDING You Understand Ahooooooo
Bullish
Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:10:09 PM
- CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results • ACCESS Newswire • 05/14/2026 08:00:00 PM
- CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026 • ACCESS Newswire • 05/12/2026 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
